ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $60,469,000 | +202.4% | 1,305,214 | +59.1% | 0.04% | +191.7% |
Q1 2019 | $19,997,000 | +111.7% | 820,305 | +23.7% | 0.01% | +71.4% |
Q4 2018 | $9,446,000 | -73.5% | 663,084 | -71.7% | 0.01% | -30.0% |
Q3 2018 | $35,638,000 | -42.1% | 2,344,733 | -36.1% | 0.01% | -44.4% |
Q2 2018 | $61,576,000 | +81.8% | 3,669,787 | +76.8% | 0.02% | +12.5% |
Q1 2018 | $33,878,000 | +91.6% | 2,076,030 | +50.3% | 0.02% | +45.5% |
Q4 2017 | $17,680,000 | +3.2% | 1,381,459 | -0.8% | 0.01% | -8.3% |
Q3 2017 | $17,131,000 | +0.8% | 1,393,058 | -31.4% | 0.01% | 0.0% |
Q2 2017 | $17,003,000 | +9.5% | 2,031,823 | +17.0% | 0.01% | +9.1% |
Q1 2017 | $15,526,000 | -42.9% | 1,736,958 | -43.8% | 0.01% | -50.0% |
Q4 2016 | $27,176,000 | +45.9% | 3,091,966 | +12.0% | 0.02% | +69.2% |
Q3 2016 | $18,632,000 | +193.6% | 2,760,731 | +54.8% | 0.01% | +225.0% |
Q2 2016 | $6,346,000 | -20.4% | 1,783,331 | -34.0% | 0.00% | -33.3% |
Q1 2016 | $7,968,000 | -31.4% | 2,702,026 | -1.9% | 0.01% | -25.0% |
Q4 2015 | $11,620,000 | +24.9% | 2,754,067 | +34.9% | 0.01% | +14.3% |
Q3 2015 | $9,306,000 | -17.1% | 2,041,593 | +31.1% | 0.01% | 0.0% |
Q2 2015 | $11,222,000 | -6.0% | 1,556,875 | -3.9% | 0.01% | 0.0% |
Q1 2015 | $11,937,000 | +85.2% | 1,620,039 | +18.8% | 0.01% | +75.0% |
Q4 2014 | $6,446,000 | +26.9% | 1,363,217 | -4.3% | 0.00% | +33.3% |
Q3 2014 | $5,081,000 | -20.4% | 1,424,464 | +1.7% | 0.00% | -25.0% |
Q2 2014 | $6,381,000 | +2.5% | 1,400,131 | +5.6% | 0.00% | 0.0% |
Q1 2014 | $6,226,000 | -10.4% | 1,325,361 | -4.5% | 0.00% | -20.0% |
Q4 2013 | $6,951,000 | -34.4% | 1,388,437 | -18.5% | 0.01% | -37.5% |
Q3 2013 | $10,594,000 | – | 1,704,137 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,850,650 | $75,330,000 | 5.64% |
BVF INC/IL | 6,682,711 | $28,201,000 | 4.81% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,729,361 | $36,838,000 | 1.49% |
First Light Asset Management, LLC | 530,391 | $2,238,000 | 0.94% |
KOPP INVESTMENT ADVISORS LLC | 376,477 | $1,589,000 | 0.78% |
Sarissa Capital Management LP | 700,000 | $2,954,000 | 0.57% |
Orbimed Advisors | 10,689,000 | $45,108,000 | 0.41% |
Bedell Frazier Investment Counselling, LLC | 178,971 | $755,000 | 0.37% |
PINNACLE ASSOCIATES LTD | 3,453,487 | $14,574,000 | 0.31% |
Artal Group S.A. | 3,710,000 | $15,656,000 | 0.29% |